ISTH mutations
  Advanced search  
Search for:             Details found: 589
Page 1 of 59
Records Per Page:
Exon No
Alleles
VWD Classification
Nucleotide Change
Amino Acid Substitution
Functional Studies
Country
Laboratory
Comments
Ref.
20 108 Type 2N 2560C>T R854W No Wales The mutation creates a restriction site for BsrI. Bowen et al., 1998
28 10 Type 2M 4273A>T I1425F Yes USA Montgomery VWF:RCo = 4-13, VWF:Ag = 13-36, normal collagen binding, normal multimers Hillery et al, 1998
Deletion exons 22-43 6 Type 3 Not Determined Null Allele No USA Sadler Deletion associated with inhibitory antibody formation to VWF. Mancuso et al., 1994
12 10 Type 2A 1309-1326del D437-R442del Yes USA Montgomery VWF from abnormal allele has no ristocetin and low botrocetin binding to platele More ...
31 6 Type 2M 5356C>G H1786D Yes USA Montgomery, ZPMCB-VWD The mutation results in defective binding to both type I and type III collagen. Flood et al., 2010
28 4 Type 2A 4735G>A G1579R No USA Robert Montgomery
28 20 Type 2M 4173-4205 del R1392-Q1402 del Yes USA Montgomery VWF:RCo = 3-8, VWF:Ag 14-35, normal multimers, no platelet binding with ristocet More ... Mancuso et al, 1996
52 2 Unclassified 8416T>C C2806R Yes USA Montgomery VWF:RCo <12 U/dl, VWF:Ag 30 U/dl, 1 band on multimer gel
28 2 Type 2B 3916C>T R1306W No USA Montgomery
Deletion exons 33-38 6 Type 3 5621-269_6799-1161del Null Allele No USA Sadler Deletion associated with inhibitory antibody formation to VWF. Mancuso et al., 1994